Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y

de Leeuw Peter W.

首页> 外文期刊>Annals of Internal Medicine >Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y

【24h】

Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y

机译：综述：针对降低到<140 mm的SBP降低到<140 mm HG，比瞄准SBP到高血压患者的SBP> = 140> = 65 y

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Internal Medicine》 |2017年第10期|共1页
作者
de Leeuw Peter W.;
展开▼
作者单位

Maastricht Univ Med Ctr Maastricht Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词

相似文献

外文文献
中文文献
专利

1. Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y [J] . de Leeuw Peter W. Annals of Internal Medicine . 2017,第10期

机译：综述：针对降低到<140 mm的SBP降低到<140 mm HG，比瞄准SBP到高血压患者的SBP> = 140> = 65 y
2. Does therapy targeting normal SBP of less than 120 mm Hg reduce major CV events in T2DM patients? [J] . Bijan Roshan Current diabetes reports. . 2011,第4期

机译：靶向正常SBP的治疗是否低于120毫米HG减少T2DM患者的主要CV事件？
3. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. [J] . Zhang Y, Zhang X, Liu L, European Heart Journal: The Journal of the European Society of Cardiology . 2011,第12期

机译：是否所有高血压患者的收缩压目标均<140 mmHg？随机FEVER试验结果的亚组分析。
4. A 140-GHz 14-dBm Power Amplifier using Power Combiner based on Symmetric Balun in 65-nm Bulk CMOS [C] . Daisuke Yamazaki, Takamichi Horikawa, Tetsuya Iizuka IEEE International Symposium on Radio-Frequency Integration Technology . 2020

机译：一个基于65 nm体CMOS的基于对称巴伦的功率合成器的140 GHz 14 dBm功率放大器
5. The implementation and analysis of the ECDSA on the Motorola StarCore SC140 DSP primarily targeting portable devices. [D] . Smith, Eric William. 2003

机译：主要针对便携式设备的Motorola StarCore SC140 DSP上ECDSA的实现和分析。
6. Diastolic blood pressure achieved at target systolic blood pressure (120–140 mm Hg) and dabigatran-related bleeding in patients with nonvalvular atrial fibrillation: A real-world study [O] . Yu Yu, Minghui Li, Wei Zhou, 2020

机译：在靶收缩压（120-140mm Hg）和非衰弱性心房颤动患者中达到靶血压（120-140mm Hg）和Dabigatran相关的出血的舒张压：真实世界的研究
7. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial [O] . Y. Zhang, X. Zhang, L. Liu, 2011

机译：在所有高血容量中表明140 mmHg是否有收缩压靶<140 mmHg？随机发热试验的亚组分析结果
8. Ada Compiler Validation Summary Report: Certificate Number: 910323W1.11133 Alsys,Inc., AlsyCOMP-033, Version 5.3, Sun 3/140 (Host) to iSBC386/12 (Target) [R] . 1991

机译：ada编译器验证摘要报告：证书编号：910323W1.11133 alsys，Inc.，alsyCOmp-033，版本5.3，sun 3/140（主机）至isBC386 / 12（目标）

Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y

著录项

相似文献

相关主题

期刊订阅